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amplification as a surveillance tool 
for malaria in reactive case detection moving 
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Abstract 
Background: As malaria transmission decreases, the proportion of infections that are asymptomatic at any given 
time increases. This poses a challenge for diagnosis as routinely used rapid diagnostic tests (RDTs) miss asympto-
matic malaria cases with low parasite densities due to poor sensitivity. Yet, asymptomatic infections can contribute 
to onward transmission of malaria and therefore act as infectious reservoirs and perpetuate malaria transmission. 
This study compared the performance of RDTs to loop-mediated isothermal amplification (LAMP) in the diagnosis of 
malaria during reactive active case detection surveillance.
Methods: All reported malaria cases in the Engela Health District of Namibia were traced back to their place of resi-
dence and persons living within the four closest neighbouring houses to the index case (neighbourhood) were tested 
for malaria infection with RDTs and dried blood spots (DBS) were collected. LAMP and nested PCR (nPCR) were carried 
out on all RDTs and DBS. The same procedure was followed in randomly selected control neighbourhoods.
Results: Some 3151 individuals were tested by RDT, LAMP and nPCR. Sensitivity of RDTs and LAMP were 9.30 and 
95.50%, respectively, and specificities were 99.27 and 99.92%, respectively, compared to nPCR. LAMP carried out on 
collected RDTs showed a sensitivity and specificity of 95.35 and 99.85% compared to nPCR carried out on DBS. There 
were 2 RDT samples that were negative by LAMP but the corresponding DBS samples were positive by PCR.
Conclusion: The study showed that LAMP had the equivalent performance as nPCR for the identification of Plas-
modium falciparum infection. Given its relative simplicity to implement over more complex and time-consuming 
methods, such as PCR, LAMP is particularly useful in elimination settings where high sensitivity and ease of operation 
are important.
© The Author(s) 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
As countries set goals to eliminate malaria, detecting a 
large fraction of infections becomes increasingly impor-
tant in order to interrupt transmission [1]. Detecting 
symptomatic cases is feasible because patients gener-
ally have high-density infections and present to health 
facilities passively where they can be detected by rapid 
diagnostic test (RDT). However, detecting asymptomatic 
infections in the community is a challenge during passive 
and reactive case detection of malaria because asympto-
matic individuals do not seek treatment. These infections 
are often low density and below the threshold of detec-
tion for microscopy and RDTs, yet can continue to infect 
mosquitoes and sustain transmission [2, 3]. This is a par-
ticular challenge for low transmission settings where evi-
dence suggests that sub-patent infections can comprise 
70–80% of all malaria infections [4].
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Active case detection, whereby infections are actively 
sought out and treated within the community, becomes 
a recommended approach [1]. Namibia has recently 
begun reactive active case detection (RACD) which 
involves testing and treating individuals living in close 
proximity to reported cases because malaria cases can 
be geographically clustered around the reported cases 
[1, 5].
Asymptomatic infections are however usually associ-
ated with sub-patent infections, below the density detect-
able (< 50 parasites/µL) by current RDTs [2]. Detection of 
these infections relies on more sensitive methods, such 
as polymerase chain reaction (PCR), which have a detec-
tion limit of 1–2 parasites/µL when extracted from a dry 
blood spot (DBS) [4, 6, 7]. While PCR is often considered 
the gold standard method of detection, it requires sub-
stantial technical expertise and infrastructure, limiting 
its operational use. An alternative method recently devel-
oped is loop-mediated isothermal amplification (LAMP). 
LAMP has been shown to have excellent diagnostic per-
formance and is simpler to perform. A number of studies 
have reported that LAMP could easily be scaled up as it 
requires minimal training and equipment and has a short 
turnaround time for results (45 min) [8]. LAMP has been 
reported to have a sensitivity highly consistent with nPCR 
and there are reports of LAMP being more sensitive than 
PCR [8–10]. Both LAMP and PCR have a high sensitiv-
ity as a result of the amplification of the detection signal, 
DNA.
The diagnostic accuracy of LAMP was compared to 
RDT using nPCR as a gold standard, in a low transmis-
sion setting of northern Namibia. In addition, blood 
samples from RDT were tested to determine if they can 
provide sufficiently high quality blood samples for molec-
ular analysis to those collect as DBSs.
Methods
This study was part of a wider epidemiological study in 
northern Namibia. Details of this study are presented 
elsewhere [11]. Briefly, all consenting individuals liv-
ing within households of cases passively detected at any 
one of the 17 health facilities in Engela Health district, 
in Ohangwena region of Namibia had blood taken for a 
RDT and a DBS. The blood samples were collected from 
consenting individuals living within four neighbour-
ing households of index cases, including the index case 
household. A total of 2642 RDT and DBS samples were 
collected. The RDT and DBS samples were stored in 
labelled, ziplock bags with desiccant at − 20 °C at a health 
facility in the field. These samples were transported to 
the laboratory on ice where they were stored (at − 20 °C) 
then processed. LAMP was run on all RDT and DBS 
samples. nPCR was run on all LAMP and RDT positive 
samples and 10% of the LAMP negative samples using 
DBS as the source of DNA.
Chelex DNA extraction
DNA was extracted from the collected RDT and DBS 
samples using the chelex extraction method. The RDT 
cassette was opened with a surgical blade and a total of 
4 pieces of similar size were cut from the nitrocellulose 
strip inside the RDT cassette with a surgical blade that 
was sterilized with ethanol and washed with water after 
each use. The DNA was concentrated between the con-
trol line and the blood loading point, the 4 pieces were 
cut from this section. There were 4 DBSs on each DBS 
sample; a small circular piece (≈ 5 mm) in diameter was 
cut from one of the 4 DBSs on the filter paper using a 
puncher that was sterilized with ethanol and washed with 
water between samples.
LAMP
In this procedure, Pan-LAMP tubes (able to detect all 4 
species of Plasmodium that infect humans) were used. 
The kits were used according to the manufacturer’s pro-
tocol (LMC 562, Eiken Chemical Co Ltd, Tokyo, Japan). 
LAMP was performed to determine the presence of 
Plasmodium parasites in the blood samples based on the 
presence or absence of Plasmodium DNA.
Cytochrome B nested-PCR targeting the genus Plas-
modium (Plasmodium falciparum, Plasmodium ovale, 
Plasmodium malariae, Plasmodium vivax) was per-
formed on every positive RDT and LAMP sample and 
on every 10th negative sample as a reference for qual-
ity assurance of DNA isolation of positive and negative 
results. The nested-PCR was run using the primers CB1 
and CB2 for the primary round, and NCB1 and NCB2 
were used for the nested round with the diluted product 
from the first round being used as a template as shown 
in Table 1. Cytochrome B nested-PCR is highly sensitive 
in detecting P. falciparum infections that are dominant in 
Namibia. The PCR conditions were as shown in Table 2. 
After the nested round of PCR, 5 µL of the PCR product 
were mixed with 2 µL of loading dye. These samples were 
then loaded onto a 2% polyacrylamide gel and run for 
110 min at 90 volts. After running the gel, it was placed 
in a gel documenting system that was connected to a 
desktop computer to visualize the results.
Data analysis
Medcalc® statistical software was used to assess diagnos-
tic performance of RDTs compared to LAMP. The diag-
nostic performance test calculates 4 parameters, which 
are sensitivity, specificity, positive predictive value (PPV), 
and negative predictive value (NPV).
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Results
Out of 2642 people screened 2642 had RDTs and 2640 
DBS available for assessment. LAMP was carried out 
on 2642 RDTs and 2640 DBS samples. nPCR was car-
ried out on 56 DBS samples corresponding to all positive 
samples by RDT and/or LAMP and 10% of negative DBS 
(Table 3).
There were 23 RDT detected malaria infections from a 
total of 2642 individuals. The sensitivity, specificity, PPV 
and NPV of RDTs were 9.30, 99.27, 17.39, and 98.51%, 
respectively.
There were 45 detected malaria infections with LAMP 
using RDT as the DNA source. These were detected with 
sensitivity, specificity, PPV and NPV of 95.35, 99.85, 
91.11, and 99.92%, respectively.
There were 47 detected malaria infections with LAMP 
using DBS as the DNA source, two times more than those 
obtained with RDTs. These were detected with sensitiv-
ity, specificity, PPV and NPV of 95.50, 99.92, 99.56, and 
99.92%, respectively. This is comparable to LAMP results 
using RDTs as the DNA source. There were 43 detected 
malaria infections from DBS with nPCR, 1.9 times more 
than those obtained with RDTs, similar to LAMP (Fig. 1).
There were 2 positive infections, picked up by LAMP 
and nPCR using DBS as the DNA source, that was nega-
tive by LAMP when RDTs were used as the DNA source. 
In addition, LAMP detected 2 malaria infections that 
were not detected by the gold standard nPCR with DBS 
as the DNA source.
Table 1 Primer sequences for  LAMP amplification of  the  Plasmodium genus for  detection of  Plasmodium falciparum, 
Plasmodium vivax, Plasmodium ovale and Plasmodium malariae 
Species Primer Primer sequence (5′ to 3′)
P. falciparum, P. vivax, P. ovale, P. malariae) Forward Inner Primer (F1P) (F1c + F2 regions) AGC TGG AAT TAC CGC GGC TGG 
GTT CCT AGA GAA ACA ATTGG 
Backward Inner Primer (B1P) (B1-B2c regions) TGT TGC AGT TAA AAC GTT CGT 
AGC CCA AAC CAG TTT AAA TGA 
AAC 
Forward Outer Primer (F3) (F3c + F3 region) TGT AAT TGG AAT GAT AGG AAT TTA 
Backward Outer Primer (B3) (B3 + B3c region) GAA AAC CTT ATT TTG AAC AAAGC 
Loop Forward Primer (LPF) GCA CCA GAC TTG CCCT 
Loop Backward Primer (LPB) TTG AAT ATT AAA GAA 
Table 2 Cycling conditions for  amplification of  the  PCR 
primary and secondary round
PCR conditions
Primary round PCR programme: 
3 h
Nested round PCR programme: 
3 h
1. Initial denaturation—94 °C × 5 m 1. Initial denaturation—94 °C × 5 m
2. 40 Cycles—94 °C × 30 s, 
52.5 °C × 90 s, 68 °C × 90 s
2. 40 Cycles—94 °C × 30 s, 
60 °C × 90 s, 72 °C × 90 s
3. Final elongation—68 °C × 10 m 3. Final elongation—72 °C × 10 m
4. Hold at 4 °C 4. Hold at 4 °C
Table 3 Diagnostic evaluation test of LAMP and RDT with nPCR as the gold standard
RDTs rapid diagnostic test, LAMP loop-mediated amplification, DBS dried blood spot, nPCR nested polymerase chain reaction
Total 
number 
tested
Number 
positive 
(%)
Number 
negative 
(%)
Sensitivity 95% 
confidence 
interval
Specificity 95% 
confidence 
interval
Positive predictive 
value
95% confidence 
interval
Negative predictive 
value
95% confidence 
interval
RDTs 2642 23 2619 9.30% (2.59–22.14%) 99.24% (98.86–
99.56%)
17.39% (6.96–
37.22%)
98.51% (98.36–
98.65%)
LAMP extracted 
from RDT
2642 45 2597 95.35% (84.19–
99.43%)
99.85% (99.61–
99.96%)
99.11% (79.34–
96.47%)
99.92% (99.70–
99.88%)
LAMP extracted 
from DBS
2640 47 2593 95.50% (84.85–
99.46%)
99.92% (99.72–
99.99%)
95.56% (84.31–
98.85%)
99.92% (99.70–
99.98%)
nPCR extracted 
from DBS
315 43 262 Reference Reference Reference Reference
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Discussion
As countries move towards elimination, interventions 
to halt malaria transmission will require more accurate 
detection of all malaria infections, both asymptomatic 
and symptomatic, with highly sensitive tools [5, 12, 13]. 
The study examined the diagnostic performance of RDT 
and LAMP using DNA extracts from both RDT and DBS. 
The study found RDT to be insensitive in detecting low 
density asymptomatic infections and LAMP to have simi-
lar performance to nPCR when performed on both RDT 
extracts and DBS.
RDTs miss community infections [14, 15]. Similarly to 
other studies [16], the number of infections detected by 
RDT nearly doubled when LAMP was used with n-PCR 
as the reference, as with this study [17]. This is likely 
due to the low detection threshold of RDT compared 
to LAMP with a detection limit four times higher than 
RDT which makes LAMP more suited for the detection 
of sub-patent infections [8, 16]. LAMP has a high sensi-
tivity because, like n-PCR, it amplifies the signal (DNA) 
for detection compared to RDT that detects antigens in 
the blood. In addition to the high sensitivity of LAMP, 
it had a short turnaround time for results [18, 19]. The 
turnaround time for results for LAMP was an 8th of the 
turnaround time for n-PCR. LAMP has a basic benchtop 
preparation process that makes it an appropriate diag-
nostic tool, even for low resource settings in health facili-
ties, compared to nPCR which requires working on ice 
and a PCR cabinet to avoid contamination. LAMP also 
requires minimal set-up in terms of equipment and train-
ing, and therefore it can be scaled up easily compared to 
nPCR.
This study examined and compared the diagnostic per-
formance of LAMP from DNA extracts from RDTs and 
LAMP because samples for further molecular analysis 
are difficult to obtain as the number of cases decreases. 
Furthermore, it would be operationally convenient and 
cheaper if RDTs that are already routinely used by health 
workers could be used for further molecular research. 
The results show comparable results when RDT and DBS 
samples are used as the sources of DNA. This could pro-
vide more samples without the extra step to collect DBS, 
especially in low transmission setting where samples are 
scarce.
LAMP detected two additional positives that were 
missed by nPCR but it missed one infection that was 
detected by nPCR. These findings could mean that 
LAMP has false positives or it could mean that LAMP is 
more sensitive. In Thailand, there were reports of LAMP 
giving 9 false positives (n = 487) using nPCR as the gold 
standard [9]. Also, results were found in Ethiopia in a 
study carried out by Sema et  al., where LAMP had one 
more positive than nPCR [17]. This may be because 
LAMP has primers that target mitochondrial DNA 
that has a higher copy number than the 18 s rDNA tar-
geted by primers used in n-PCR [20–22]. In addition to 
this, LAMP uses a more robust polymerase, Bst, which 
is less affected by inhibitors that affect the reaction effi-
ciency in n-PCR, which uses the Taq polymerase [23, 
Fig. 1 A gel showing PCR positive samples. First lane—50 bp Ladder; lane PC—Positive control; lanes 1, 2, 3, 4, 5, 6, 7—Positive samples indicating 
the presence of malaria infections; lane NC—negative control
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24]. In addition, LAMP is a low-cost alternative to PCR 
(no expensive thermocyclers required) with comparable 
sensitivity to n-PCR (about 70 US$0.70 per sample com-
pared to US$5-7 per sample using DNA amplification by 
real-time PCR). LAMP can be run on a heat block that 
has several uses in the laboratory, including DNA extrac-
tions, incubation and activation of cultures, enzyme reac-
tions and blood urea nitrogen determinations. LAMP 
is also used to detect other infectious diseases, such as 
tuberculosis and sleeping sickness, as an alternative to 
PCR. However, LAMP is currently more expensive than 
RDT, therefore, is likely to be used for quality control and 
detection of malaria hotspots. Beyond malaria, LAMP 
has been shown to be at least equally useful in diagno-
sis and detection of pathogens using only a heating block 
after DNA extraction. WHO has recommended the use 
of Tuberculosis LAMP (TB-LAMP\ as a replacement 
for microscopy for the diagnosis of pulmonary tubercu-
losis in adults with signs and symptoms of tuberculosis 
[25]. Microbiological water quality has been determined 
using DNA extracts from environmental waters to detect 
human enteric pathogens, which are a threat to public 
health, using only a heating block [26].
The diagnostic evaluation test gives an indication and 
comparison of how effective a diagnostic tool is com-
pared to other diagnostic tools. The parameters meas-
ured by the evaluation test are sensitivity, specificity, PPV 
and NPV. The results from the diagnostic evaluation test 
show that the probability of detecting a malaria infection 
is quadrupled with the use of LAMP rather than RDT 
[27]. Therefore, the use of LAMP becomes important in 
RACD in order to detect sub-patent infections that are 
missed by RDT as a result of their poor sensitivity at low 
parasite density.
Conclusion
When conducting RACD for malaria the majority of 
malaria infections are asymptomatic and infections are of 
lower density than symptomatic cases, therefore LAMP, 
conducted on either stored RDTs or DBS samples, per-
formed better than RDT. Although LAMP requires 
minimum equipment, training and preparation making 
it suitable for low resource settings and operationally 
convenient, malaria programmes may still choose to use 
RDT to inform immediate clinical care of those testing 
positive. New, more sensitive RDTs are now in develop-
ment but it is yet to be seen how they compare to LAMP 
and other molecular tests in the field.
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